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Abstract 
Chronic subdural hematoma (CSDH) 
formation mechanism is very complex, and has 
not entirely understood. It represents a frequent 
type of intracranial hemorrhage, and is very 
common disease in Neurosurgery practice, 
especially in older patients. Various surgical 
treatments have been proposed for the treatment 
of CSDH. The rate of recurrence in CSDH after 
surgery ranges from 5% to 30%, repeated surgery 
must be considered. But in some cases subdural 
collections are still persistent. Endovascular 
embolization of the middle meningeal artery 
(MMA) is an option for treatment of refractory 
CSDH. We review all cases that were treated with 
embolization to assess the effect of this 
intervention. Our review revealed 6 papers with 
a total enrollment of 14 patients were treated 
with MMA embolization for refractory chronic 
subdural hematoma without any postoperative 
complication or recurrence. In this study we 
suggest MMA embolization as an alternative for 
treatment of non-curable CSDH, especially for 
old people with systematic diseases, who cannot 
tolerate repeat surgery. 
Introduction 
Chronic subdural hematoma (CSDH) is a 
common neurological condition, particularly 
for older patients (1, 2), with an estimated 
incidence of 7.32 per 100,000 people per year 
for individuals above 70 years old (3). Levels of 
mortality associated with CSDH range from 
1.5% to 8% (4). The pathogenesis of CSDH 
formation remains unclear, although new 
imaging and molecular biology techniques 
have improved our understanding of these 
processes (5, 6). The rate of recurrence in 
CSDH after surgery with any of actual 
techniques (Burr-hole surgery with irrigation 
and drainage, twist drill, craniotomy) ranges 
from 5% to 30% (7, 8, 9). Patients who have 
high risk factors for recurrence, especially with 
coagulopathy10 or under anticoagulant 
therapy (11), hematoma may be recur after the 
first intervention, and repeated surgery must 
be considered. The treatment options remains 
controversial. A number of techniques are 
used to manage recurring CSDH, including 
burr hole plus drainage, repeated irrigation, 
the installation of reservoirs and aspiration 
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(12), subdural peritoneal shunts (13), capsule 
removal with large craniotomy, and the 
endoscopic perforation of the septum (14). 
For elderly patients, however, efforts 
should be made to avoid the repeated 
application of invasive procedures. 
Embolization of the middle meningeal artery 
(MMA) is another treatment option for 
frequently recurring CSDH. This procedure is 
often used to treat dural arteriovenous shunts 
or as a preoperative treatment for meningioma 
tumors. MMA embolization was first used to 
treat CSDH in 2000, preventing CSDH 
recurrence in a patient with cirrhosis of the 
liver (15). 
Here we have evaluated whether MMA 
embolization effectively prevents the 
recurrence of hematoma in patients with 
CSDH. 
A search of the literature revealed six 
reports concerning 14 patients. These patients 
were 55–87 years old and had follow-up 
periods of 3–18 months. None of the patients 
treated with MMA embolization for refractory 
CSDH experienced any postoperative 
complications or hematoma recurrence. This 
analysis suggests that MMA embolization is an 
effective, alternative treatment for non-
curable CSDH, especially for older patients 
with systematic diseases who cannot tolerate 
multiple surgeries. 
Methods 
To identify relevant case reports in the 
scientific literature, the Medline, PubMed, 
Embase, and ISI Web of Science databases 
were searched using the key words “chronic 
subdural hematoma" combined with 
"recurrence" and "embolization" or "middle 
meningeal artery". Only patients who received 
MMA embolization for the treatment of 
recurrent CSDH were included in the analysis. 
Articles not available in English were 
excluded. After identifying relevant articles, all 
studies referenced by these manuscripts were 
also reviewed. Our search identified six 
publications that describe outcomes for 14 
patients treated with MMA embolization. 
Included studies were case series that 
presented class III evidence. 
Results 
Among the 14 patients who met our 
inclusion criteria were 12 males and two 
females, with ages that ranged from 55 to 87 
years (Table 1). Seven patients had suffered a 
previous head trauma; three patients had not 
experienced a trauma; trauma histories were 
not available for three patients; and for patient 
number 9 the history of head trauma was 
unclear. Patients presented with symptoms 
that included abnormal behavior, 
disorientation, speech abnormalities, 
dementia, motor weakness, hemiparesis, gait 
disturbances, and loss of consciousness. 
Three patients were taking the anticoagulant 
Warfarin (Coumadin), one patient had 
coagulopathy from cirrhosis of the liver, one 
patient was on hemodialysis because of chronic 
renal failure, one patient was receiving 
chemotherapy for peritoneal mesothelioma, one 
patient was receiving  treatment for 
dentatorubral-pallidoluysian atrophy, one 
patient was suffering from alcoholism, and six 
patients had no previous medical histories. Based 
on computed tomography scans, six patients had 
bilateral CSDH, whereas eight patients had one-
sided CSDH. 
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TABLE 1 
Patients’ characteristics 
author Patient 
No. 
Age sex Head  
Trauma? 
Pre-treatment 
Symptoms 
Past medical 
history 
CSDH 
on    CT 
 pre-embolization 
treatments  
Embolization 
Materials 
Follow-up 
(months) 
major 
treatments 
other 
treatments 
Mandai  
et al.15 
1 59 M no LOC, 
hemiparesis 
coagulopathy 
from cirrhosis 
of the liver 
1) 
bilateral  
2) MLS 
burr hole, 
irrigation 
 
Ommaya 
reservoir 
PVA 
particles 
7 
Hirai  
et al.27 
2 81 M yes motor 
weakness, gait 
disturbance 
warfarin 
(aortic valve 
replacement) 
bilateral burr hole, 
irrigation 
 
irrigation PVA 
particles, 
platinum 
coils 
10 
 3 63 M yes abnormal 
behavior, 
disorientation 
warfarin 
(cardiomyop-
athy) 
right  
side 
burr hole, 
irrigation, 
drainage 
irrigation platinum 
coils 
unavailable 
Ishihara  
et al.28 
4 78 M yes unavailable hemodialysis 
(chronic renal 
failure) 
left  side burr hole, 
drainage 
 
none 20% NBCA 16 
Mino  
et al.29 
5 73 M yes gait 
disturbance 
none bilateral burr hole, 
drainage 
irrigation gelatin 
sponge, GDC 
 
6 
 6 79 M no speech 
disturbance, 
dementia 
none right 
side 
burr hole, 
drainage 
Craniotomy gelatin 
sponge, GDC 
 
6 
 7 65 M yes hemiparesis none left side burr hole, 
drainage 
none gelatin 
sponge, GDC 
6 
 8 75 M yes gait 
disturbance 
none bilateral burr hole, 
drainage 
none gelatin 
sponge,  GDC 
6 
Tsukamoto 
et al.30 
9 64 M unclear consciousness 
disturbance 
DRPLA bilateral Burr hole, 
drainage 
steroids PVA particles 18 
Hashimoto 
et al.31 
10 79 M yes none peritoneal 
mesothelioma 
right 
side 
Burr hole, 
irrigation 
none 16% NBCA 3 
 11 55 M unavailable unavailable Heavy drinker left side Burr hole, 
irrigation 
none 20% NBCA unavailable 
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 12 87 M unavailable unavailable none left side Burr hole, 
irrigation 
none 16% NBCA unavailable 
 13 73 F unavailable unavailable none bilateral Burr hole, 
irrigation 
none 18% NBCA 
200-μm PVA 
particles 
unavailable 
 14 68 F no Disorientation warfarin 
(Cerebral 
infarction, 
pulmonary 
Embolism) 
left side Burr hole, 
irrigation 
none 20% NBCA 4 
CSDH, chronic subdural hematoma; DRPLA, dentatorubral-pallidoluysian atrophy; GDC, Guglielmi detachable 
coils; MLS, midline shift; NBCA, N-butyl 2-cyanoacrylate; LOC, loss of consciousness; PVA, polyvinyl alcohol 
 
TABLE 2 
Factors associated with the recurrence of CSDH* 
Patient factors Laboratory findings Imaging findings Surgical factors 
-age 
-sex 
-low GCS 
-low GOS at discharge 
-hemodialysis 
-dementia 
-diabetes 
-epilepsy 
-APs or ACs 
-chemotherapeutic agents 
-intracranial  hypotension (CSF shunt 
surgery) 
-hypertension 
-alcoholism  
-postoperative patient posture 
-liver dysfunction 
-renal failure  
-thrombocytepenia 
-coagulation-factor 
deficiency 
-brain atrophy 
-high and mixed-density 
CSDH 
-bilateral CSDH 
-midline shift more than 5 
mm 
-width of the hematoma 
-cranial base hematoma 
-septum formation 
-duration of 
drainage 
-residual air after 
surgery 
 
*These factors are still controversial 
AC, anticoagulant; AP, antiplatelet; CSF,crebrospinal fluid; GCS, Glasgow coma scale, GOS, Glasgow outcome 
scale 
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The first treatment that these patients 
received were: 1) burr hole plus drainage and 
irrigation, 2) burr hole plus drainage, or 3) 
burr hole plus irrigation. Several techniques 
were also used to treat hematoma recurrence, 
namely an additional surgery, irrigation, an 
Ommaya reservoir, and steroids. The 
materials used to embolize the MMA were: 
polyvinyl alcohol particles, 16–20% N-butyl 2-
cyanoacrylate, gelatin sponges, and Guglielmi 
detachable coils. 
No complications were reported after the 
MMA embolization procedure. Follow-up 
times ranged from 3 to 18 months, although 
follow-up times for patients 3, and 11–13 were 
not available. Importantly, all 14 patients 
experienced no recurrences or enlargements 
of CSDH following embolization of the MMA. 
Discussion 
CSDH is one of the most common types of 
intracranial hemorrhage and it is associated 
with high levels of morbidity and mortality 
(1.5–8%) (4, 16, 17). Patients with advanced 
age are more likely to have CSDH because of 
atrophy of the brain parenchyma. This 
atrophy enlarges subarachnoid spaces, thereby 
stretching veins that bridge these spaces (18). 
Stretched veins are more fragile and tend to 
rupture, releasing venous blood into the 
subdural space (19). Men are twice as likely as 
women to have CSDH because they experience 
more head injuries (20). Single or double burr 
holes with closed drainage systems (with or 
without irrigation) are currently the 
treatments of choice for this condition, but 
many others techniques have been described 
(21). The recurrence of CSDH following 
surgery is not uncommon, and can result from 
poor re-expansion of the brain, or 
inflammation and hemorrhage of the outer 
membrane (22). 
Several factors are associated with CSDH 
recurrence, including advanced age, a 
tendency to bleed, brain atrophy, alcohol 
abuse, kidney and liver diseases, diabetes, 
epilepsy, anticoagulants, chemotherapy 
agents, intracranial hypotension, 
hemodialysis, the density of the hematoma, 
the width of the hematoma, insufficient 
intraoperative drainage, postoperative 
accumulation of air in the subdural space, 
bilateral CSDH, postoperative position, the 
Glasgow coma scale, and the Glasgow 
outcome scale (7, 11, 16, 17, 23–26) (Table 2). 
Analyses concerning these associations, 
however, have yielded inconsistent results. 
The treatment of recurrent CSDH remains 
controversial and many techniques have been 
used to manage this condition, including burr 
holes plus drainage, repeated irrigations, the 
installation of reservoirs and aspiration (12), 
subdural peritoneal shunts (13), capsule 
removal with large craniotomy, endoscopic 
perforation of the septum (14), and MMA 
embolization (15, 27–32). 
Embolization of the MMA to treat CSDH 
was first reported by Mandai et al. (15) for 
patients with coagulopathy (cirrhosis of the 
liver). Application of this technique resulted in 
very positive patient outcomes. In one 
Japanese article Takahashi et al. (32) reported 
results concerning three patients with 
recurrent CSDH that had been subjected to 
several unsuccessful drainage procedures. 
After MMA embolization no hematoma 
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enlargements were seen and all hematomas 
gradually and completely resolved (32). 
Tanaka et al. (33) performed superselective 
angiography of the MMA in a series of 35 
patients. They found diffuse dilation of the 
MMA and scattered networks of abnormal 
vasculature, which seemed to be 
macrocapillaries within the outer membrane 
(29, 33). To understand the relationship 
between the MMA and the outer membrane in 
CSDH, Tanaka et al. (34) studied histological 
features of the outer membrane and observed 
many communicating arteries, i.e., arteries 
that originated from branches of the MMA 
and then entered the outer membrane. They 
concluded that the MMA provides nutrients to 
the abnormal membrane that surrounds the 
hematoma via these communicating arteries. 
As direct arterial pressure of the MMA may 
rupture these communicating arteries, MMA 
embolization may prevent or delay CSDH 
recurrence. 
The most common materials used for the 
embolization procedure were: N-butyl 2-
cyanoacrylate, Guglielmi detachable coils, 
polyvinyl alcohol particles, and gelatin 
sponges. Using a low concentration of liquid 
N-butyl 2-cyanoacrylate increases the 
therapeutic effect by embolizing more 
peripheral vessels associated with the MMA 
with a low risk of catheter adhesion (28, 31). 
To prevent the aberrant flow of blood into the 
ophthalmic artery, it is necessary to perform a 
pre-embolization study of the MMA pathway 
and its anastomosis with the internal carotid 
artery through the inferolateral trunk, or the 
feeding vessel to the facial nerve.  If there is 
anastomosis between the MMA and the 
ophthalmic artery, embolization of the 
proximal MMA using coils or gelatin sponges 
should be considered (31). 
Here we have review 14 cases in which 
MMA embolization was used to treat CSDH. 
None of these patients had post-operative 
complications, CSDH recurrence, or CSDH 
enlargement. It should be acknowledged, 
however, that this review does not contain 
Class I or Class II data, and that this analysis 
should be supplemented with more deﬁnitive 
data (e.g., randomized trials) when they 
become available. Results to date indicate that 
embolization of the MMA represents an 
effective option for treating recurrent CSDH. 
It is is good option for patients who cannot 
tolerate invasive intervention such as repeated 
surgery (burr hole), capsule removal with large 
craniotomy or perforation of the septum with 
an endoscope. It can use as adjuvant therapy in 
treating recurrence of chronic subdural 
hematoma. 
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